Category: Vaccine

BRASILIA (Reuters) - The vaccination records of Brazil's former president Jair Bolsonaro are false, the country's comptroller general's office said on Thursday after an investigation regarding the alleged tampering of information on his COVID-19 vaccination card.

The records show that Bolsonaro, a COVID-19 skeptic who publicly opposed the vaccine, received a dose of the immunizer in a public healthcare center in Sao Paulo in July 2021.

The investigation concluded, however, that the former president had left the city the previous day and didn't leave Brasilia until three days later, according to a statement.

The nurse listed in the records as having applied the vaccine on Bolsonaro denied doing so and was no longer working at the center. The listed vaccine lot was also not available on that date, the comptroller general's office said.

Registration of two other vaccine doses that would have been given to Bolsonaro was removed from his record even before the investigations began, it added, saying these were also fake.

Last May, Bolsonaro's home in Brasilia was raided by the federal police under the vaccine probe. Some of his aides were arrested and his cell phone was seized.

Bolsonaro has previously denied having knowledge of or ordering false information to be inserted into his vaccination records.

His lawyer did not immediately respond to a request for comment.

During his tenure, Bolsonaro repeatedly downplayed the importance of immunization and social distancing measures during the pandemic. He often stated that he had not been vaccinated against the disease and would not do so.

He also dismissed the effectiveness of vaccines and spread fears about the possible side effects of immunization, going so far as to falsely associate the vaccine with the development of AIDS.

Bolsonaro was infected with COVID-19 in July 2020, nearly one year before the record of his first vaccine.

(Reporting by Ricardo Brito and Peter Frontini; Editing by Sandra Maler)

See original here:

Brazil's Bolsonaro's vaccination records are false, authorities say - Yahoo News

Country music legend Trace Adkins is speaking out about the COVID-19 vaccine.

And, sorry anti-vaxxers, you are not going to like what he has to say.

The 62-year-old recently appeared on Bill Mahers Club Random podcast and had a wide-ranging discussion with the comedian. Among the topics was COVID-19 with Adkins noting that his mother got COVID three times and beat it.

And shes 81, he said. The first time she got it was pretty rough, but then the next two times it wasnt very bad. She had built up a natural immunity, I suppose.

Adkins said he also got COVID, twice, before noting that he had gotten the vaccine.

Thats when Maher chimed in with, So you didnt think the vaccine had a chip in it to track you?

Buckle up conspiracy theorists. What comes next is going to fire you up.

You know what? Adkins said. I just dont buy all of that crap, you know? Im like, Give me a vaccine for everything that youve got one for. Ill take them. Im not scared of that.

I dont think theyre trying to put something in the vaccines to control us.

Surprisingly, there has yet to be much of a social media blowback directed toward Adkins, but its 2024 so it is probably coming.

Adkins last album, The Way I Wanna Go, dropped in 2021. He has four Billboard number-one hits (This Aint) No Thinkin Thing, Ladies Love Country Boys, Youre Gonna Miss This, and Hillbilly Bone. He has also been plenty busy in his acting career, last appearing in Among Wolves, which was released in December of 2023.

Original post:

Country music legend speaks out on COVID-19 vaccine and some folks wont like what he said - PennLive

The Therapeutic Goods Administration (TGA) has approved a vaccine against respiratory syncytial virus (RSV) in Australia for the first time. The shot, called Arexvy and manufactured by GSK, will be available by prescription to adults over 60.

RSV is a contagious respiratory virus which causes an illness similar to influenza, most notably in babies and older adults.

So while it will be good to have an RSV vaccine available for older people, where is protection up to for the youngest children?

Read more: What happens in our body when we encounter and fight off a virus like the flu, SARS-CoV-2 or RSV?

RSV was discovered in chimpanzees with respiratory illness in 1956, and was soon found to be a common cause of illness in humans.

There are two key groups of people we would like to protect from RSV: babies (up to about one year old) and people older than 60.

Babies tend to fill up hospitals during the RSV season in late spring and winter in large numbers, but severe infection requiring admission to intensive care is less common.

In babies and younger children, RSV generally causes a wheezing asthma-like illness (bronchiolitis), but can also cause pneumonia and croup.

Although there are far fewer hospital admissions among older people, they can develop severe disease and die from an infection.

For older adults, there are actually several RSV vaccines in the pipeline. The recent Australian TGA approval of Arexvy is likely to be the first of several, with other vaccines from Pfizer and Moderna currently in development.

The GSK and Pfizer RSV vaccines are similar. They both contain a small component of the virus, called the pre-fusion protein, that the immune system can recognise.

Both vaccines have been shown to reduce illness from RSV by more than 80% in the first season after vaccination.

Read more: Is there a vaccine for RSV or respiratory syncytial virus? After almost 60 years, several come at once

In older adults, side effects following Arexvy appear to be similar to other vaccines, with a sore arm and generalised aches and fatigue frequently reported.

Unlike influenza vaccines which are given each year, it is anticipated the RSV vaccine would be a one-off dose, at least at this stage.

Younger babies dont tend to respond well to some vaccines due to their immature immune system. To prevent other diseases, this can be overcome by giving multiple vaccine doses over time. But the highest risk group for RSV are those in the first few months of life.

To protect this youngest age group from the virus, there are two potential strategies available instead of vaccinating the child directly.

The first is to give a vaccine to the mother and rely on the protective antibodies passing to the infant through the placenta. This is similar to how we protect babies by vaccinating pregnant women against influenza and pertussis (whooping cough).

The second is to give antibodies directly to the baby as an injection. With both these strategies, the protection provided is only temporary as antibodies wane over time, but this is sufficient to protect infants through their highest risk period.

Abrysvo, the Pfizer RSV vaccine, has been trialled in pregnant women. In clinical trials, this vaccine has been shown to reduce illness in infants for up to six months. It has been approved in pregnant women in the United States, but is not yet approved in Australia.

An antibody product called palivizumab has been available for many years, but is only partially effective and extremely expensive, so has only been given to a small number of children at very high risk.

A newer antibody product, nirsevimab, has been shown to be effective in reducing infections and hospitalisations in infants. It was approved by the TGA in November, but it isnt yet clear how this would be accessed in Australia.

Read more: How common are severe side effects from COVID vaccines? And how are they detected?

RSV, like influenza, is a major cause of respiratory illness, and the development of effective vaccines represents a major advance.

While the approval of the first vaccine for older people is an important step, many details are yet to be made available, including the cost and the timing of availability. GSK has indicated its vaccine should be available soon. While the vaccine will initially only be available on private prescription (with the costs paid by the consumer), GSK has applied for it to be made free under the National Immunisation Program.

In the near future, we expect to hear further news about the other vaccines and antibodies to protect those at higher risk from RSV disease, including young children.

Continue reading here:

An RSV vaccine has been approved for people over 60. But what about young children? - The Conversation Indonesia

1 hour ago

Gemma Larkman-Jones, pictured with son Samuel, wants to share her story to help highlight the risks of SSPE and measles

A mother whose child died aged six from a brain inflammation caused by measles hopes sharing her story will encourage parents to "vaccinate more".

It comes as the UK Health Security Agency (UKHSA) warned of measles outbreaks in parts of London.

Gemma Larkman-Jones wants more parents to consider having their children vaccinated sooner.

Her son, Samuel, developed a rare form of brain inflammation after catching measles, and died in 2019.

"I honestly think that if people knew that this was a possibility they would vaccinate more," Ms Larkman-Jones, 45, of Brixton, south London, told the PA Media news agency.

"Even if it just makes one parent question how many lives could that one child being vaccinated save?

"I don't want any other parent to go through this."

Vaccination rates across the UK have been dropping, but there are particular concerns in parts of the capital as well as in some areas of the West Midlands.

Ms Larkman-Jones believes Samuel's death was avoidable had he been vaccinated with the measles, mumps and rubella (MMR) jab, but she said he had been put on a delayed vaccination programme.

Samuel developed measles aged two in 2014 and recovered, but was admitted to hospital in 2019 after his mother noticed he often lost his balance while walking

In February 2019 Samuel was transferred to St Thomas' Hospital where a lumbar puncture and an MRI test found he had the neurological disorder subacute sclerosing panencephalitis (SSPE).

Ms Larkman-Jones said weeks later Samuel fell into a "vegetative state" and died on 30 April.

"Samuel didn't need to die and that's the guilt I carry every day with me," she said.

"People just think it's a bit of a temperature, but I think they've forgotten that people can go blind, people can go deaf, people who seemingly sailed through measles can end up years down the line with SSPE," she said.

"I honestly do believe that people just think that measles, like chickenpox, is part of being a child and it's so not.

"I think (my story) will make people think 'although it's a risk, it's still a risk, am I going to risk my child dying for something that he doesn't need to?'"

Listen to the best of BBC Radio London on Sounds and follow BBC London on Facebook, X and Instagram. Send your story ideas to hello.bbclondon@bbc.co.uk

Link:

Mum urges vaccine push and shares how son died after catching measles - BBC.com

Van Buren, Cass County health officials urge vaccination as COVID cases surge

by Donny Ede | News Channel 3

FILE - A flu vaccine is readied at the L.A. Care and Blue Shield of California Promise Health Plans' Community Resource Center in Lynwood, Calif., on Friday, Oct. 28, 2022. (AP Photo/Mark J. Terrill, File)

WEST MICHIGAN

The Van Buren/Cass District Health Department, or VBCDHD, is issuing a strong recommendation for the public to get vaccinated against influenza and COVID-19 after a surge in cases.

Health officials said the recent surge is concerning, and vaccination is a critical tool to prevent overwhelming the healthcare system and protect public health.

A%20graph%20showing%20surging%20COVID-19%20cases%20in%20Van%20Buren%20and%20Cass%20Counties.%20(VBCDHD/WWMT)

Officials encourage eligible people 6 months and older to receive their annual flu shot, and make sure they're up to date on their COVID-19 vaccine.

The health department also ask the public to fill out a survey to help them better understand the community's beliefs on vaccines and to ensure their actions are best serving the community.

More information on vaccine availability, clinics, and additional resources visit the VBCDHD's website here, or call (269) 621-3143 and ask to speak to a public health nurse.

Load more...

Read the original here:

Van Buren, Cass County health officials urge vaccination as COVID cases surge - WWMT-TV

NEW YORK (AP) A New York midwife who gave nearly 1,500 children homeopathic pellets instead of required vaccinations has been fined $300,000, the states health department announced this week.

Jeanette Breen, who operates Baldwin Midwifery on Long Island, administered the pellets as an alternative to vaccinations and then falsified their immunization records, the agency said Wednesday.

The scheme, which goes back least to the 2019-2020 school year, involved families throughout the state, but the majority reside on suburban Long Island. In 2019, New York ended a religious exemption to vaccine requirements for schoolchildren.

The health department said immunization records of the children who received the falsified records have been voided, and their families must now prove the students are up-to-date with their required shots or at least in the process of getting them before they can return to school.

Misrepresenting or falsifying vaccine records puts lives in jeopardy and undermines the system that exists to protect public health, State Health Commissioner James McDonald said in a statement.

Breen, a state-licensed healthcare provider, supplied patients with the Real Immunity Homeoprophylaxis Program, a series of oral pellets that are marketed as an alternative to vaccination but are not recognized or approved by state or federal regulators as valid immunizations, according to the health department.

She administered 12,449 of the fake immunizations to roughly 1,500 school-aged patients before submitting information to the states immunization database claiming the children had received their required vaccinations against measles, mumps, rubella, polio, chickenpox, diphtheria, tetanus, pertussis, hepatitis B and a host of other diseases, the department said.

Breens lawyer said Thursday that his client cooperated with investigators, paid her fine and intends to comply with all other requirements of her agreement with health officials.

Suffice it to say, Ms. Breen has provided excellent midwifery services for many years to many families, especially on Long Island. She is now toward the end of her career, David Eskew wrote in an emailed statement. From her perspective, this matter is over, done with, and closed and she is now moving on with her life.

As part of the settlement, Breen has paid $150,000 of the $300,000 penalty, with the remainder suspended contingent upon her complying with state health laws and never again administering any immunization that must be reported to the state, according to the health department. Shes also permanently banned from accessing the states immunization records system.

Erin Clary, a health department spokesperson, said Thursday that while parents and legal guardians had sought out and paid Breen for her services, they werent the focus of the agencys investigation.

State health officials say theyre now in the process of notifying hundreds of affected school districts.

Read the original here:

NY midwife who gave kids homeopathic pellets instead of vaccines fined $300K for falsifying records - The Associated Press

With fewer residents getting vaccinated for respiratory illnesses and more visitors traveling throughout the state, Hawaii has seen an increase in flu cases in recent weeks.

Chad Shibuya, an infection control nurse manager at Hilo Medical Center, has been monitoring flu, COVID-19 and RSV cases in the emergency room throughout the flu season, which began in August 2023.

When you go month-by-month, there are more flu cases than anything else. COVID in comparison is low, and cases of RSV increased but have now leveled off, Shibuya said. However, this January, weve had more COVID than flu, so there is fluctuation.

From October to December, 250 cases of Influenza A, 139 cases of Influenza B, 187 cases of RSV and 21 cases of COVID were hospitalized at HMC.

This month, Influenza A and RSV have been trending down, COVID is trending up, and Influenza B has become rare, according to Shibuya.

When we look at the respiratory viruses going on right now, there are not many hospitalizations compared to previous years, and risk groups remain the same, Shibuya said. Mostly patients 60-years and older end up in the hospital. Occasionally, we will admit a pediatric case, but they are rare, and they dont stay long.

The state Department of Health on Tuesday announced the first influenza-associated death of a Hawaii resident under the age of 18 during this flu season. The child was an Oahu resident.

Unlike flu activity in other states, flu transmission in Hawaii is observed year-round.

Im not sure specifically why our flu season is longer than that of states on the mainland, but the flu does travel in a pattern, Shibuya said. We have visitors coming from all over the world, as well as residents traveling more and spending more time indoors during the holidays. All of this can allow the flu to spread easily.

At Queens North Hawaii Community Hospital in Waimea, there were 178 cases of influenza from October to December 2023, compared to 101 cases for the same period in 2022.

(Reasons for) an increase in cases could be that people are out more and not wearing masks, said Lynn Scully, marketing and communications manager for QNHCH. Flu usually peaks here in Hawaii a bit later than the U.S. mainland, so it is safe to expect that our cases will continue to increase.

While there are more cases of the flu this year, their severity is not the worst that Hawaii Island has seen. However, recovery can still take a long time, according to Dr. Christine Chan with East Hawaii Health Clinics.

Once the virus passes through the respiratory system, it causes inflammation, and that damage can take three to four weeks to repair, Chan said. Even if youre better in a few days, there are long-term social consequences after illness with many people developing a post-viral cough.

State Epidemiologist Sarah Kemble recommends that everyone 6 months and older get vaccinated against the flu.

While this years flu season began in August, there is still time to get a flu vaccine because Hawaiis flu season can last until April.

It takes two weeks to build immunity from the flu vaccine, so its important to get the vaccine early, around August or September, said Chan. Because the season is so long, you can still build immunity to protect yourself and others through February, March and April.

According to Shibuya, one reason why fewer people are getting flu shots is the overall public fatigue surrounding vaccinations.

People are tired of talking about vaccines, even if they arent opposed to them. Each year, there are COVID, flu and RSV shots recommended, and people are not getting them as much, Shibuya said. It is still a good idea to get vaccinated every year, because you never know if youll be that one person who gets really sick, and getting those shots will reduce the risk.

Health experts highly recommend vaccines against respiratory viruses for vulnerable populations such as those with heart disease, diabetes, asthma, COPD and people over 65.

Protection with the flu vaccine can reduce rates of cardiovascular events, which can cause inflammation and damage to the heart, kidneys, brain and body in general, Chan said. If people do have symptoms, we urge them to see primary care doctors, Urgent Care clinics, or go to the emergency room if its serious, as soon as possible.

A list of COVID-19 and flu vaccination locations can be found at vaccines.gov.

Email kelsey Walling at kwalling@hawaiitribune-herald.com.

Read the original post:

Health care workers tout flu vaccines as cases expected to increase - West Hawaii Today

Share this Article

You are free to share this article under the Attribution 4.0 International license.

A Johns Hopkins virologist has answers for you about the latest COVID variant.

Vaccines, tests, and antivirals are still effective tools against the most recent COVID surge, says Andy Pekosz, a professor in the molecular microbiology and immunology department at the Johns Hopkins University Bloomberg School of Public Health

In early November 2023, the JN.1 variant caused less than 5% of COVID-19 cases in the US. Now it is estimated to cause more than 60% of them. Virologists, including Pekosz, are paying attention.

Here, he explains what virologists are seeing, what this new variant means for case rates and treatments, and why its so important for more people to get the updated COVID-19 vaccine rolled out this fall:

View post:

What you should know about the latest COVID variant - Futurity: Research News

For pregnant people, three doses of an mRNA COVID-19 vaccine resulted in 10-fold higher antibody levels in umbilical cord samples of preterm and full-term deliveries compared with only two doses, a prospective cohort study showed.

Geometric mean concentration of cord SARS-CoV-2 anti-Spike (anti-S) antibodies increased from 1,000 after two doses of vaccine to 9,992 for those who received three or more doses (P<0.001), reported Alisa Kachikis, MD, of the University of Washington in Seattle, and colleagues in JAMA Network Open.

In addition, concentrations of SARS-CoV-2 anti-S antibodies in paired maternal blood samples significantly increased, from 674 in those who received two vaccine doses to 8,159 in those who received 3 or more doses (P<0.001).

Notably, cord anti-S antibody levels were similar in preterm and full-term pregnancies, with geometric mean concentrations of 8,818 and 10,423, respectively (P=0.34). After adjusting for vaccine timing and dose number before delivery, there was no association between preterm delivery and cord anti-S antibody levels (=0.44, 95% CI -0.06 to 0.94).

"We were surprised that, when adjusted for vaccine dose number and time from last vaccine dose, preterm babies received similar benefit from COVID-19 vaccines given to their mothers compared to term babies," Kachikis told MedPage Today. "It shows that maternal antibody concentrations matter and we should consider high-risk pregnancies when thinking about timing of vaccines during pregnancy."

For both preterm and full-term pregnancies, the median time between last vaccine dose and delivery was 16 weeks, and the median gestational age at last vaccine dose was 25 weeks.

"Changes in antibody levels didn't really seem to correlate much with gestational age at the time of birth, so we shouldn't necessarily time a booster injection to the last few weeks of pregnancy thinking that's going to be most protective for the newborn," Angela Bianco, MD, director of maternal-fetal medicine at the Icahn School of Medicine at Mount Sinai in New York City, told MedPage Today. "We probably should encourage women even earlier in pregnancy or at the outset of pregnancy to get boosted if they haven't already."

A study from October showed that maternal mRNA COVID-19 vaccination during pregnancy protected young infants from COVID-related hospitalization, and another study found that maternal vaccination lowered risks of poor neonatal outcomes. However, a recent CDC survey showed that although 58.7% of pregnant women had completed the primary COVID vaccination series, only 27.3% reported receiving an updated booster dose before or during their current pregnancy.

The current study enrolled 220 pregnant individuals at the University of Washington from February 2021 through January 2023. All had received at least two doses of mRNA COVID vaccine before giving birth and had no history of prior COVID infection (confirmed by the absence of anti-SARS-CoV-2 nucleocapsid antibodies at delivery). The median age of participants was 34 years, and approximately 82% were white.

Among participants, 121 received two doses of an mRNA vaccine and 99 received three or more vaccine doses, before or during pregnancy. Of the 36 preterm deliveries, the median gestational age was 35.1 weeks, but ranged from approximately 28 to 37 weeks, including 19.4% delivered at less than 34 weeks. The 184 full-term infants were delivered at a median 39.5 weeks. Cesarean section delivery was more common among preterm infants than those carried to full term (66.7% vs 35%, respectively).

Kachikis and colleagues noted that the study was limited by its small sample size. Because selection criteria required participants to have received at least two doses of an mRNA vaccine, the study population was limited to those with high vaccine acceptance rates.

Bianco also noted that the study population was mostly white individuals with private health insurance who had never had COVID. Additionally, very few early preterm deliveries were included and the researchers did not specify the causes of preterm deliveries. These factors mean the findings of the study might not apply to other populations, she explained.

Katherine Kahn is a staff writer at MedPage Today, covering the infectious diseases beat. She has been a medical writer for over 15 years.

Disclosures

The study was funded by grants from the National Institute of Allergy and Infectious Diseases, the Women's Reproductive Health Research Award, the Thrasher Research Fund, and the National Center for Advancing Translational Sciences.

Kachikis reported working as an unpaid consultant for Pfizer and GlaxoSmithKline and as a co-investigator for Merck and Pfizer outside the submitted work.

One co-author reported receiving grants from AstraZeneca, GSK, Pfizer, and Merck, and personal fees from AbbVie, AstraZeneca, Meissa Vaccines, Moderna, Sanofi Pasteur, Pfizer, and Ark Biopharma. Another reported receiving grants from Gilead and central testing contracts with Abbott, Pfizer, Cepheid, Novavax, Janssen, and Hologic.

Bianco reported no ties to industry.

Primary Source

JAMA Network Open

Source Reference: Kachikis A, et al "Timing of maternal COVID-19 vaccine and antibody concentrations in infants born preterm" JAMA Netw Open 2024; DOI: 10.1001/jamanetworkopen.2023.52387.

Go here to read the rest:

Newborns Better Protected With 3 Doses of Maternal COVID Vaccine - Medpage Today

MMR

Parents advised to check vaccination status of children, with full uptake of MMR jab down to average of 85%

Further outbreaks of measles could spread across Britain, the UK Health Security Agency (UKHSA) has warned, after declaring a national incident amid a surge in cases and low vaccine uptake.

Recent figures from the agency revealed a sharp rise in the number of measles cases, with uptake of the measles, mumps and rubella (MMR) vaccine at its lowest level in more than a decade and well under the recommended coverage, the UKHSA chief executive, Dame Jenny Harries, has said.

This is a call right across the country for all parents to check the vaccination rates of their children, Harries told BBC Radio 4s Today programme as she was due to travel to the West Midlands, which has had the largest recent outbreak of the infection outside London.

Data released by the agency earlier this week showed that, since last October, there were 216 lab-confirmed cases in the West Midlands, with 103 cases likely. About 80% of the cases were in Birmingham and 10% were in Coventry, according to the agency, citing low vaccination rates. Most of the cases were among children aged under 10.

The average number of children starting school having had both MMR doses has dropped to 85%, said Harries, with figures in some areas of the West Midlands down to 81% and just above 70% in the NHS Surrey Heartlands region. Birmingham childrens hospital has treated more than 50 measles cases in the last month, according to the BMJ.

We are well under the recommended coverage for MMR vaccination, said Harries. Its clearly not where we want the vaccination programme to be, we want it to be 95%.

Measles can begin with cold-like symptoms followed by a rash. It can lead to severe illness, with an estimated 20-40% of children hospitalised, according to the UKHSA. The disease was considered eliminated in the UK in 2016 and 2017, meaning transmission had stopped, but resurfaced in 2018.

The MMR jab is given to children in two doses: the first when they are one, and a second when they are aged three years and four months. The World Health Organization recommends that at least 95% of children be inoculated for diseases that can be stopped by vaccines.

According to the UKHSA, between January and November 2023, there were 209 lab-confirmed cases of measles in England, nearly half of which were in London. The agency said cases were on the rise after outbreaks in the West Midlands, Yorkshire and the Humber.

The call for vaccination comes amid concern that the virus is spreading to London, where up to 20% of children are entering school unvaccinated, according to Harries. Thats a significant risk to the London population, she said, while urging young adults to also get vaccinated.

In July, the UKHSA carried out a risk assessment and warned the capital of the risk of a major measles outbreak that could result in tens of thousands of cases, dozens of deaths and thousands of hospitalisations.

Predictably, were seeing that swing more to other particularly inner-city areas where we know vaccination rates are low, and we know large numbers of children will be congregating together, said Davies.

London has the lowest percentage of children who have received both doses, according to data from NHS for the year 2022-23, with Hackney in east London at 56.3%, followed by Camden in north London at 63.6%.

In areas such as Camden , mobile vaccination clinics are being offered as more than a quarter of children are starting school without their two MMR vaccinations, said Kirsten Watters, the councils director of health and wellbeing.

When talking to parents, we know that most do intend to vaccinate their children and theyve got high levels of confidence and trust, said Watters. Its just that theyre finding it difficult to organise those appointments.

One of the reasons for vaccine uptake varying among different communities includes the use of porcine gelatine in an MMR vaccine. Since MMR vaccines are available that do not contain porcine gelatine, Harries said information needs to be made more available and to be given by trusted community leaders.

Its clearly important that communities have good information in a way which is meaningful for them, its accessible to them, and that doesnt necessarily mean just a pamphlet or a translation, weve seen that through the pandemic, said Harries.

Generally, despite our concerns, the UK population are confident in the vaccine delivery and particularly in the advice they get from primary care and the NHS, she added.

{{topLeft}}

{{bottomLeft}}

{{topRight}}

{{bottomRight}}

{{.}}

One-timeMonthlyAnnual

Other

Go here to see the original:

Surge in measles cases prompts UK to declare national health incident - The Guardian